Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Profound neurological injury in a patient with atypical hemolytic uremic syndrome.

Literature DB >> 23139014

Profound neurological injury in a patient with atypical hemolytic uremic syndrome.

Galena Salem, Joseph M Flynn, Spero R Cataland.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 2012 PMID： 23139014 DOI： 10.1007/s00277-012-1615-y

Source DB: PubMed Journal: Ann Hematol ISSN： 0939-5555 Impact factor: 3.673

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

1. Macrovascular involvement in a child with atypical hemolytic uremic syndrome.

Authors: Karolis Ažukaitis; Chantal Loirat; Michal Malina; Irina Adomaitienė; Augustina Jankauskienė
Journal: Pediatr Nephrol Date: 2013-12-19 Impact factor: 3.714

Review 2. An international consensus approach to the management of atypical hemolytic uremic syndrome in children.

Authors: Chantal Loirat; Fadi Fakhouri; Gema Ariceta; Nesrin Besbas; Martin Bitzan; Anna Bjerre; Rosanna Coppo; Francesco Emma; Sally Johnson; Diana Karpman; Daniel Landau; Craig B Langman; Anne-Laure Lapeyraque; Christoph Licht; Carla Nester; Carmine Pecoraro; Magdalena Riedl; Nicole C A J van de Kar; Johan Van de Walle; Marina Vivarelli; Véronique Frémeaux-Bacchi
Journal: Pediatr Nephrol Date: 2015-04-11 Impact factor: 3.714

3. Eculizumab therapy for atypical haemolytic uraemic syndrome due to a gain-of-function mutation of complement factor B.

Authors: Rodney D Gilbert; Darren J Fowler; Elizabeth Angus; Stephen A Hardy; Louise Stanley; Timothy H Goodship
Journal: Pediatr Nephrol Date: 2013-04-28 Impact factor: 3.714

Profound neurological injury in a patient with atypical hemolytic uremic syndrome.

1. Macrovascular involvement in a child with atypical hemolytic uremic syndrome.

Review 2. An international consensus approach to the management of atypical hemolytic uremic syndrome in children.

3. Eculizumab therapy for atypical haemolytic uraemic syndrome due to a gain-of-function mutation of complement factor B.

Review 4. Extra-renal manifestations of atypical hemolytic uremic syndrome.

5. Remission of aHUS neurological damage with eculizumab.

6. Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea.

7. Cerebral vascular injury in transplant-associated thrombotic microangiopathy.

Review 8. Critical appraisal of eculizumab for atypical hemolytic uremic syndrome.